Timing & pharmacokinetics
How long does Fisetin take to work?
Onset timing for Fisetin varies in the clinical literature. Onset timing is not well-quantified in our dataset — refer to clinical citations on the main entry.
Onset
—
Half-life
—
Duration
—
Timing
AM
Key facts
- typical dose
- 100–500 mg
- dose frequency
- 1 dose (cycle)
- timing
- AM
- with food
- with fat
- safety score
- 4/5
- evidence grade
- B
- class
- neuroprotective
- PubMed citations
- 1700
- legal status (US)
- Over-the-counter
- legal status (UK)
- Over-the-counter
- legal status (EU)
- Over-the-counter
- legal status (AU)
- Over-the-counter
- primary mechanism
- Senolytic activity — selectively induces apoptosis in senescent cells (cells that have stopped dividing but remain metabolically active and inflammatory).
Onset window
Fisetin onset times in the published literature vary widely. Refer to the citations on the main Fisetin entry for compound-specific pharmacokinetic data.
Food effect: Fisetin is fat-soluble — onset is faster and more reliable with a fat-containing meal. Empty-stomach dosing delays effect.
Half-life and dosing frequency
Half-life is not characterised in our dataset.
Acute vs. chronic effect
Some nootropics work the first time you take them (Fisetin may or may not). Others — adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways — require 2–4 weeks of daily dosing before the full effect emerges.
If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal — extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.
Protocol note from the Fisetin entry
Many use intermittent (2 days/month) senolytic protocols.
Mechanism, safety, and citations for Fisetin are on the main reference page — see Fisetin. For full dose protocol see Fisetin dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.
Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.